Integral Molecular
Publicly observedPhiladelphia, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Philadelphia | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Integral Molecular | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | DY9KSWE8EJB8 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2024Publicly observed
NIH SBIR/STTR award: Specificity Screening Drug Development Tool for Biotherapeutic Safety
USD 879,255.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2024Publicly observed
NIH SBIR/STTR award: Specificity Screening Drug Development Tool for Biotherapeutic Safety
USD 929,016.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2024Publicly observed
NIH SBIR/STTR award: Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses
USD 288,515.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2023Publicly observed
NIH SBIR/STTR award: High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
USD 631,033.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2023Publicly observed
NIH SBIR/STTR award: High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA
USD 923,143.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.